JPS6155882B2 - - Google Patents
Info
- Publication number
- JPS6155882B2 JPS6155882B2 JP5659383A JP5659383A JPS6155882B2 JP S6155882 B2 JPS6155882 B2 JP S6155882B2 JP 5659383 A JP5659383 A JP 5659383A JP 5659383 A JP5659383 A JP 5659383A JP S6155882 B2 JPS6155882 B2 JP S6155882B2
- Authority
- JP
- Japan
- Prior art keywords
- organ
- container
- temperature
- refrigerant
- perfusion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 210000000056 organ Anatomy 0.000 claims description 54
- 230000010412 perfusion Effects 0.000 claims description 36
- 239000007788 liquid Substances 0.000 claims description 22
- 238000007710 freezing Methods 0.000 claims description 21
- 230000008014 freezing Effects 0.000 claims description 19
- 238000010257 thawing Methods 0.000 claims description 17
- 239000003507 refrigerant Substances 0.000 claims description 16
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 14
- 239000012530 fluid Substances 0.000 claims description 11
- 239000003795 chemical substances by application Substances 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- 239000008280 blood Substances 0.000 claims description 9
- 210000004369 blood Anatomy 0.000 claims description 9
- 238000001816 cooling Methods 0.000 claims description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 8
- 210000001367 artery Anatomy 0.000 claims description 7
- 210000003240 portal vein Anatomy 0.000 claims description 7
- 235000011187 glycerol Nutrition 0.000 claims description 4
- 210000003462 vein Anatomy 0.000 claims description 4
- 239000002577 cryoprotective agent Substances 0.000 claims description 3
- 210000001835 viscera Anatomy 0.000 claims 1
- PXBRQCKWGAHEHS-UHFFFAOYSA-N dichlorodifluoromethane Chemical compound FC(F)(Cl)Cl PXBRQCKWGAHEHS-UHFFFAOYSA-N 0.000 description 11
- 238000000034 method Methods 0.000 description 11
- 239000000243 solution Substances 0.000 description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 7
- 238000002054 transplantation Methods 0.000 description 5
- 239000007798 antifreeze agent Substances 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 238000004321 preservation Methods 0.000 description 4
- 230000002528 anti-freeze Effects 0.000 description 3
- 230000036760 body temperature Effects 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 230000008081 blood perfusion Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 230000002262 irrigation Effects 0.000 description 2
- 238000003973 irrigation Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000002595 cold damage Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- NBVXSUQYWXRMNV-UHFFFAOYSA-N fluoromethane Chemical compound FC NBVXSUQYWXRMNV-UHFFFAOYSA-N 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N methyl monoether Natural products COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
Landscapes
- Agricultural Chemicals And Associated Chemicals (AREA)
Description
【発明の詳細な説明】
本発明は人体等から摘出した各種の臓器を貯蔵
できるよう処理したり、貯蔵臓器を適時移殖のた
め解凍処理することのできる臓器の保存解凍用装
置に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to an apparatus for preserving and thawing organs, which is capable of processing various organs extracted from the human body so that they can be stored, and thawing stored organs for timely transplantation.
従来より摘出臓器を移殖時まで保存することが
行なわれているが、当該保存手段としては臓器の
動脈または門脈から、血液と近似した性質をもつ
約4℃のコリンズ液を注入して、これを静脈から
排出させる所謂潅流法なるものが知られており、
このような潅流処理後の臓器は上記4℃程度の温
度条件にて貯蔵され、移殖に際して貯蔵臓器に血
流を付与してから用いるようにしている。 Conventionally, extracted organs have been preserved until transplantation, and the preservation method involves injecting Collins fluid at a temperature of approximately 4°C, which has properties similar to blood, through the organ's artery or portal vein. A so-called perfusion method is known that drains this through the veins.
The organ after such perfusion treatment is stored under the above-mentioned temperature condition of about 4° C., and blood flow is applied to the stored organ at the time of transplantation before use.
しかし当該保存方法によるときは臓器の保存可
能限度は12時間程度であり、このため臓器の供与
と需要との時間的調整が難事となり、人命の救済
にも大きな隘路となつている。 However, when using this preservation method, organs can only be preserved for about 12 hours, which makes it difficult to coordinate the time between organ donation and demand, creating a major bottleneck in saving human lives.
そこで保存時間を延長させるため、貯蔵温度条
件を低温として当該臓器を凍結することも考えら
れるが、上記従来法を施した臓器を凍結させると
細胞破壊が起こり、臓器自体を死滅させてしまう
ことゝなる。 Therefore, in order to extend the storage time, it is possible to freeze the organ by setting the storage temperature to a low temperature, but freezing the organ subjected to the above conventional method will cause cell destruction and cause the organ itself to die. Become.
本発明は上記の点に鑑み、細胞破壊を起こさせ
ることなく摘出臓器を凍結し、半永久的な保存を
可能にすると共に、これを臓器の移殖に際して
は、その解凍に使用することのできる装置を提供
しようとするのが、その目的である。 In view of the above points, the present invention has been devised as an apparatus that enables semi-permanent preservation by freezing extracted organs without causing cell destruction, and which can also be used to thaw organs when transplanting them. Its purpose is to provide the following.
本発明を図示の実施例によつて詳記すれば、摘
出した臓器1を収納自在とした断熱容器2は、開
閉扉3を有し、当該容器2と潅流凍結解凍部4と
が、同部4の流液供給パイプ5に連結されている
と共に、断熱容器2に貫設されている流入パイプ
6によつて連結され、この流入パイプ6は臓器1
の動脈1aか門脈1bに連結され、さらに静脈1
cには断熱容器2に貫設の排出パイプ7が連結さ
れるのであり、さらに同容器2内に設けられた給
気ノズル8に、上記潅流凍結解凍部4の給気パイ
プ9が連結されて使用される。 To describe the present invention in detail with reference to the illustrated embodiment, a heat insulating container 2 capable of storing an extracted organ 1 has an opening/closing door 3, and the container 2 and the perfusion freezing/thawing section 4 are in the same part. The inflow pipe 6 is connected to the fluid supply pipe 5 of the organ 1 and connected to the fluid supply pipe 5 of the organ 1 .
is connected to the artery 1a or the portal vein 1b, and further connected to the vein 1
A discharge pipe 7 extending through the heat insulating container 2 is connected to c, and an air supply pipe 9 of the perfusion freezing and thawing section 4 is connected to an air supply nozzle 8 provided in the same container 2. used.
こゝで第1図の潅流凍結装置4は、断熱した外
槽10と中間槽11との間に液体窒素LN2が貯留
され、中間槽11とフロン等の冷媒12が収納さ
れている内槽13との間に、ヘリウムガスGHeが
封入されてなる冷却槽14を具有し、同槽14に
は先ず液剤供給機構Aが設けられている。 In the perfusion freezing device 4 shown in FIG. 1, liquid nitrogen LN 2 is stored between an insulated outer tank 10 and an intermediate tank 11, and the intermediate tank 11 and an inner tank contain a refrigerant 12 such as fluorocarbon. 13, there is provided a cooling tank 14 in which helium gas GHe is sealed, and the tank 14 is first provided with a liquid agent supply mechanism A.
当該機構Aとして同図に示したものは、上記冷
媒12中にコリンス液、ジメチルスルオキシド
(DMSO)かグリセリン、そしてアルコールを
夫々収納した第1、第2、第3容器15,16,
17が浸漬されており、コントローラー18によ
る制御により、同容器15,16,17の流出パ
イプに設けた第1、第2、第3開閉弁19,2
0,21が適時開閉作動され、前記流液供給パイ
プ5に設けたポンプ22の稼動によつて、前記コ
リンズ液、DMSO、アルコールが選択的に臓器1
の動脈1aまたは門脈1bへ供給され得るように
なつている。 The mechanism A shown in the figure includes first, second, and third containers 15, 16, each containing Corinth liquid, dimethyl sulfoxide (DMSO) or glycerin, and alcohol in the refrigerant 12, respectively.
17 is immersed, and under the control of the controller 18, the first, second, and third on-off valves 19, 2 provided in the outflow pipes of the same containers 15, 16, 17 are immersed.
0 and 21 are opened and closed at appropriate times, and the pump 22 provided in the fluid supply pipe 5 is operated to selectively supply the Collins solution, DMSO, and alcohol to the organ 1.
can be supplied to the artery 1a or the portal vein 1b.
これに対し、第2図に略示されている液剤供給
機構Aは、その第1、第2、第3容器15,1
6,17が冷却槽14外に設けられており、第
1、第2、第3開閉弁19,20,21とポンプ
22との間に形成した熱交換部23を、冷却槽1
4の冷媒12中に浸漬した構成となつている。 On the other hand, the liquid supply mechanism A schematically shown in FIG.
6 and 17 are provided outside the cooling tank 14, and a heat exchange section 23 formed between the first, second, and third on-off valves 19, 20, 21 and the pump 22 is connected to the cooling tank 1.
It has a configuration in which it is immersed in the refrigerant 12 of No. 4.
さらに当該冷却槽14には、上記冷媒12の温
度を調整自在とした冷媒用温度制御機構Bが設け
られており、図示例では冷媒12中に浸漬された
温度センサー24、撹拌器25、電気ヒーター2
6を具備し、当該センサー24と電気ヒーター2
6が、前記コントローラー18に接続され、図中
25′は撹拌器25のモーターを示している。 Furthermore, the cooling tank 14 is provided with a refrigerant temperature control mechanism B that can freely adjust the temperature of the refrigerant 12, and in the illustrated example, a temperature sensor 24 immersed in the refrigerant 12, a stirrer 25, and an electric heater. 2
6, the sensor 24 and the electric heater 2
6 is connected to the controller 18, and 25' in the figure represents the motor of the stirrer 25.
さらにまた冷却槽14には、臓器用温度制御機
構Cが設けられており、その構成は液体窒素等を
収納した臓器用冷媒ボンベ27から、冷媒12中
に浸漬された給気用容器28にLN2が供給される
と共に、同容器28から流出したLN2は、熱交換
器29により所望温度に調整された窒素ガスGN2
として、前記の給気パイプ9を介し給気ノズル8
に供給されるようになつており、図中30は前記
流液供給パイプ5に設けた開閉弁を示す。 Furthermore, the cooling tank 14 is provided with an organ temperature control mechanism C, which has a structure in which LN is transferred from an organ refrigerant cylinder 27 containing liquid nitrogen or the like to an air supply container 28 immersed in the refrigerant 12. 2 is supplied, and the LN 2 flowing out from the same container 28 is converted into nitrogen gas GN 2 whose temperature is adjusted to a desired temperature by a heat exchanger 29.
As, the air supply nozzle 8 is passed through the air supply pipe 9.
In the figure, 30 indicates an on-off valve provided in the fluid supply pipe 5.
そこで上記の装置を用いるには、先ずコントロ
ーラー18により第1開閉弁19を開き、ポンプ
22の稼動により第1容器15からコリンズ液等
による血液均等潅流液を供給するのであり、これ
により当該潅流液は臓器1の動脈1aまたは門脈
1bから同器1内に流入し、静脈1cから外部へ
排出されることになるが、この際血液均等潅流液
は、コントローラー18により冷媒用温度制御機
構Bを制御して冷媒12の温度を調整すること
で、徐々に降温させながら注入するのである。 Therefore, in order to use the above-mentioned device, the controller 18 first opens the first on-off valve 19, and the pump 22 is operated to supply a blood equalization perfusion solution such as Collins solution from the first container 15. will flow into the organ 1 from the artery 1a or portal vein 1b of the organ 1, and will be discharged to the outside from the vein 1c. By controlling and adjusting the temperature of the refrigerant 12, the injection is performed while gradually lowering the temperature.
すなわち摘出した臓器1は最初略体温である37
℃となつているから、当該体温から血液均等潅流
液の温度を徐々に降下させて行くのであり、当該
潅流液の注入により臓器1の血液は排出されて同
潅流液に置換されることゝなり、このような第1
潅流工程は、血液均等潅流液がその凝固点以前の
第1近傍降下温度となるまで続行する。 In other words, the extracted organ 1 is initially at approximately body temperature37
℃, the temperature of the blood-equalizing perfusate is gradually lowered from the body temperature, and by injecting the perfusate, the blood in organ 1 is drained and replaced with the same perfusate. , the first like this
The perfusion process continues until the blood homologous perfusate is at a first near-decreased temperature below its freezing point.
こゝで上記降温の調整は、外槽10内のLN2か
ら中間槽11内のGHeを介して冷却されている冷
媒12を、前記冷媒用温度制御機構Bにより上記
の如く制御して行なうのであり、コリンズ液の凝
固点は約0℃であるから第1潅流工程では約1〜
2℃程度が第1近傍降下温度となるよう降温制御
すればよく、例えば前記体温37℃から2℃まで血
液均等潅流液を降温させるには、降温速度を3.5
℃/minとし約10分の潅流時間とすることができ
る。 Here, the adjustment of the temperature drop is performed by controlling the refrigerant 12, which is being cooled from the LN 2 in the outer tank 10 through the GHe in the intermediate tank 11, as described above, by the refrigerant temperature control mechanism B. Since the freezing point of Collins solution is approximately 0°C, the temperature in the first perfusion step is approximately 1~1°C.
It is sufficient to control the temperature drop so that the first neighborhood temperature drop is about 2°C. For example, in order to lower the temperature of the blood perfusate from the body temperature of 37°C to 2°C, the temperature drop rate should be 3.5°C.
°C/min and the perfusion time can be approximately 10 minutes.
尚こゝで前記の熱交換器29を稼動させること
により給気ノズル8から温度制御されたGN2を噴
出させるが、これは断熱容器2内の雰囲気温度を
可及的に、降温変化する血液均等潅流液の温度と
等しくし、臓器1の内外温度に温度勾配をもたせ
ないようにするためであり、このことは以下の工
程でも続行されることになる。 At this point, by operating the heat exchanger 29, the temperature-controlled GN 2 is ejected from the air supply nozzle 8. This is to make the temperature equal to that of the perfusate and to prevent a temperature gradient between the internal and external temperatures of the organ 1, and this will continue in the following steps.
次に第1開閉弁19を閉じて第2開閉弁20を
開くよう制御して、第2容器16内の前記したジ
メチルスルオキシド、グリセリン等による凍害防
止剤を、上記血液均等潅流液に替えて臓器1へ供
給潅流する第2潅流工程に移行させるのである。 Next, the first on-off valve 19 is controlled to close and the second on-off valve 20 is opened, and the antifreeze damage agent such as dimethyl sulfoxide and glycerin in the second container 16 is replaced with the blood equalization perfusion liquid. The second perfusion step is then carried out to supply and perfuse the organ 1.
そして同工程では最初凍害防止剤が上記の第1
近傍降下温度(2℃)となつているが、これを冷
媒用温度制御機構Bにより制御することで、徐々
に降温させて行き、当該凍害防止剤がその凝固点
以前の第2近傍降下温度となるまで、これを続け
る。 In the same process, the antifreeze agent is first added to the
By controlling this temperature with the refrigerant temperature control mechanism B, the temperature is gradually lowered, and the temperature of the antifreeze damage agent becomes the second temperature drop below its freezing point. Continue this until.
こゝでDMSOの凝固点は約−5℃であるから、
第2近傍降下温度は−4℃程度とするのがよく、
実際上前記第1近傍降下温度の2℃から−4℃ま
で降温させるには、0.3℃/minで約20分の潅流時
間とすることができ、このような凍害防止剤の潅
流によつて、同剤と臓器1の細胞内における水分
との浸透圧差により、当該水分は凍害防止剤によ
り充分に吸収されることゝなる。 Since the freezing point of DMSO is approximately -5℃,
The temperature drop in the second neighborhood is preferably about -4℃,
In fact, in order to lower the temperature from 2°C to -4°C, which is the first temperature drop in the first vicinity, the perfusion time can be set at 0.3°C/min for about 20 minutes, and by perfusion of such antifreeze agent, Due to the osmotic pressure difference between the agent and the water in the cells of organ 1, the water is sufficiently absorbed by the antifreeze agent.
上記第2潅流工程が完了したならば、第3潅流
工程に移行するが、これには第2開閉弁20を
閉、第3開閉弁21を開として上記凍害防止剤に
替えて前記アルコール等凍害防止剤よりも低凝固
点の最終潅流液を供給潅流させるのである。 Once the second perfusion step is completed, the third perfusion step is started, in which the second on-off valve 20 is closed, the third on-off valve 21 is opened, and the antifreeze agent is replaced with the alcohol, etc. A final perfusate with a lower freezing point than the inhibitor is supplied for perfusion.
こゝで当該工程でも最終潅流液は前記第2近傍
降下温度(−4℃)から徐々に降温制御して潅流
させるのであり、当該潅流は最終潅流液がその凝
固点以前の第3近傍温度となるまでか、同潅流液
が凍結して潅流が停止されてしまうまで続行する
のであり、アルコールの場合その凝固点は約−80
℃であるから例えば−60℃を第3近傍降下温度と
してもまた−80℃としてもよい。 Therefore, in this step as well, the temperature of the final perfusate is controlled to gradually decrease from the second temperature drop (-4°C), and the perfusion brings the final perfusate to a third temperature below its freezing point. Perfusion continues until the perfusion fluid freezes and perfusion is stopped; in the case of alcohol, the freezing point is approximately -80°C.
For example, -60°C may be set as the third neighborhood drop temperature or -80°C.
そして実際上この第3潅流工程は、アルコール
を−4℃から−37℃まで降温させるのに0.1℃/mi
nの降下速度に約330分の潅流時間をかけ、さら
に−37℃から−60℃までの降温条件として5℃/
minの降下速度、約5分の潅流時間とすることが
できる。 In fact, this third perfusion step is 0.1℃/mi to lower the temperature of alcohol from -4℃ to -37℃.
By multiplying the perfusion time of approximately 330 minutes by the rate of descent of n, and further increasing the temperature by 5℃/
The drop rate may be 1 min, and the perfusion time may be approximately 5 min.
以上第1乃至第3潅流工程を経て得られた凍結
臓器は当該凍結状態にて保存することになるが、
これには凍結臓器を、上記実施例の場合−80℃程
度の冷凍庫に保管するとか、また液体窒素等の液
化ガス中に浸漬して貯蔵するなどの手段をとれば
よい。 The frozen organs obtained through the first to third perfusion steps above will be stored in the frozen state.
This can be done by storing the frozen organ in a freezer at about -80° C. in the case of the above example, or by storing it by immersing it in a liquefied gas such as liquid nitrogen.
さてこのように貯蔵されている凍結臓器は、こ
れを解凍して移殖の用に供することになるが、当
該解凍の手段は前記凍結のための工程を実質的に
逆行させることによつて実施することができる。 Now, the frozen organs stored in this way will be thawed and used for transplantation, but the means for thawing is carried out by substantially reversing the freezing process described above. can do.
すなわち凍結臓器を貯臓箇所から取り出して前
記第1図に示す状態にセツトすることになるが、
この際先ず断熱容器2内の雰囲気温度を徐々に昇
温させることにより、当該臓器の血管中に存する
前記アルコール等の最終潅流液を、その凝固点以
上に昇温させて解凍した後、第3開閉弁21の開
成によりアルコール等をポンプ22により潅流さ
せる。 That is, the frozen organ is removed from the storage site and set in the state shown in FIG.
At this time, first, by gradually raising the atmospheric temperature in the heat insulating container 2, the final perfusate such as alcohol present in the blood vessels of the organ concerned is raised to a temperature above its freezing point and thawed, and then the third opening/closing step is performed. When the valve 21 is opened, alcohol or the like is perfused by the pump 22.
そしてこの第1解凍潅流工程は、最終潅流液を
冷媒用温度制御機構Bによつて徐々に昇温させな
がら、その温度が前記第2近傍降下温度(−4
℃)となるまで続行するのである。 In this first thawing perfusion step, the temperature of the final perfusion liquid is gradually raised by the refrigerant temperature control mechanism B until the temperature reaches the second neighborhood drop temperature (-4
The process continues until the temperature reaches ℃).
次に上記最終潅流液に替えて前掲凍害防止剤を
潅流させる第2解凍潅流工程に移行することにな
るが、こゝでも第2近傍降下温度(−4℃)から
徐々に昇温させていき、凍結防止剤の温度が前記
第1近傍降下温度(1〜2℃)となるまで潅流を
続けることゝなる。 Next, the process will move on to the second thawing perfusion step in which the above-mentioned cryoprotectant is perfused in place of the final perfusion solution, but here too, the temperature is gradually raised from the second neighborhood drop temperature (-4°C). The perfusion is continued until the temperature of the antifreeze reaches the first temperature drop (1 to 2° C.).
さらに上記凍害防止剤に替えて前掲コリンズ液
等の血液均等潅流液を、上記第1近傍降下温度か
ら徐々に昇温させながら潅流させるが、当該第3
解凍潅流工程は、血液均等潅流液が体温程度とな
るまで続けられる。 Furthermore, in place of the above-mentioned anti-freezing agent, a blood equalization perfusion solution such as the above-mentioned Collins solution is perfused while gradually raising the temperature from the above-mentioned first neighborhood drop temperature.
The thaw-perfusion step is continued until the blood-isolated perfusate is at about body temperature.
かくして全解凍潅流工程を経た臓器は、これに
所要の血液を付与し移殖に供し得ることになる。 The organ that has undergone the complete thawing and perfusion process can be supplied with the necessary blood and used for transplantation.
本発明は上記実施例によつて具現される通り、
潅流凍結解凍部4と臓器1を収脱自在とした断熱
容器2とを具備し、潅流凍結解凍部4はフロン等
の冷媒12を収納した断熱されている冷却槽14
と、コントローラー18により当該冷媒12の温
度を調整自在とした冷媒用温度制御機構Bと、臓
器用冷媒ボンベ27から冷媒が供与される給気用
容器28を冷却槽14内の冷媒12に浸漬すると
共に、この給気用容器28は熱交換器29を介し
て給気パイプ9に連結してなる臓器用温度制御機
構Cと、コリンズ液等血液均等潅流液の第1容器
15、ジメチルスルオキシド、グリセリン等凍害
防止剤の第2容器16、アルコール等低凝固点最
終潅流液の第3容器17からコントローラー18
による制御によつて選択的に当該液剤を流液供給
パイプ5に流出させる液剤供給機構Aとからな
り、上記臓器用温度制御機構Cの給気パイプ9を
前記断熱容器2内の給気ノズル8に連結すると共
に、液剤供給機構Aの流液供給パイプ5は同断熱
容器2内の臓器1にあつて、その動脈1aまたは
門脈1bに連結自在であり、当該臓器1の静脈1
cに連結自在な排出パイプ7を断熱容器2外に延
出するようにしたから、冷媒用温度制御機構Bに
よつて冷媒12の温度を自由に調整でき、当該調
整温度によつて血液均等潅流液、冷害防止剤、そ
して低凝固点最終潅流液を夫々適時液剤供給機構
Aによつて臓器1へ送り込むことができ、しかも
臓器用温度制御機構Cによつて、断熱容器2内の
温度をも調整できるので臓器1に対する潅流が、
不本意な温度勾配なしに行ない得ることゝなり、
既に詳記した保存方法、解凍方法を支障なく実施
することができる。 The present invention, as embodied by the above embodiments,
The perfusion freezing and thawing section 4 is equipped with a perfusion freezing and thawing section 4 and an insulating container 2 in which the organ 1 can be freely put in and taken out.
Then, a refrigerant temperature control mechanism B whose temperature of the refrigerant 12 can be freely adjusted by a controller 18, and an air supply container 28 to which refrigerant is supplied from an organ refrigerant cylinder 27 are immersed in the refrigerant 12 in the cooling tank 14. In addition, this air supply container 28 includes an organ temperature control mechanism C connected to the air supply pipe 9 via a heat exchanger 29, a first container 15 for blood perfusion liquid such as Collins solution, dimethyl sulfoxide, A second container 16 for a cryoprotectant such as glycerin, a third container 17 for a final irrigation fluid with a low freezing point such as alcohol, and a controller 18
and a liquid agent supply mechanism A that selectively flows out the liquid agent to the flowing liquid supply pipe 5 under the control of The fluid supply pipe 5 of the fluid supply mechanism A can be freely connected to the artery 1a or the portal vein 1b of the organ 1 in the insulated container 2, and can be freely connected to the artery 1a or portal vein 1b of the organ 1.
Since the discharge pipe 7, which can be freely connected to the insulating container 2, extends outside the heat-insulating container 2, the temperature of the refrigerant 12 can be freely adjusted by the refrigerant temperature control mechanism B, and the adjusted temperature allows uniform blood perfusion. Liquid, cold damage preventive agent, and low-freezing point final irrigation liquid can be sent to the organ 1 by the liquid supply mechanism A in a timely manner, and the temperature inside the heat-insulating container 2 can also be adjusted by the organ temperature control mechanism C. Therefore, the perfusion to organ 1 is
This can be done without undesired temperature gradients,
The preservation method and thawing method already described in detail can be carried out without any problem.
第1図は本発明に係る臓器の保存解凍用装置に
係る一実施例の一部縦断構成説明図、第2図は同
装置の他実施例を示した要部の構成説明図であ
る。
1……臓器、2……断熱容器、4……潅流凍結
解凍部、5……流液供給パイプ、7……排出パイ
プ、8……給気ノズル、9……給気パイプ、12
……冷媒、14……冷却槽、15……第1容器、
16……第2容器、17……第3容器、18……
コントローラー、19……第1開閉弁、20……
第2開閉弁、21……第3開閉弁、22……ポン
プ、23……熱交換部、24……温度センサー、
25……撹拌器、26……電気ヒーター、27…
…臓器用冷媒ボンベ、28……給気用容器、29
……熱交換器、A……液剤供給機構、B……冷媒
用温度制御機構、C……臓器用温度制御機構。
FIG. 1 is a partially longitudinal structural explanatory diagram of one embodiment of the apparatus for preserving and thawing organs according to the present invention, and FIG. 2 is a structural explanatory diagram of main parts showing another embodiment of the same apparatus. DESCRIPTION OF SYMBOLS 1... Organ, 2... Insulated container, 4... Perfusion freezing and thawing section, 5... Fluid supply pipe, 7... Discharge pipe, 8... Air supply nozzle, 9... Air supply pipe, 12
... Refrigerant, 14 ... Cooling tank, 15 ... First container,
16...Second container, 17...Third container, 18...
Controller, 19...First on-off valve, 20...
Second on-off valve, 21...Third on-off valve, 22...Pump, 23...Heat exchange section, 24...Temperature sensor,
25... Stirrer, 26... Electric heater, 27...
... Organ refrigerant cylinder, 28 ... Air supply container, 29
...Heat exchanger, A...Liquid supply mechanism, B...Temperature control mechanism for refrigerant, C...Temperature control mechanism for organs.
Claims (1)
容器とを具備し、潅流凍結解凍部はフロン等の冷
媒を収納した断熱されている冷却槽と、コントロ
ーラーにより当該冷媒の温度を調整自在とした冷
媒用温度制御機構と、臓器用冷媒ボンベから冷媒
が供与される給気用容器を冷却槽内の冷媒に浸漬
すると共に、この給気用容器は熱交換器を介して
給気パイプに連結してなる臓器用温度制御機構
と、コリンズ液等血液均等潅流液の第1容器、ジ
メチルスルオキシド、グリセリンなど凍害防止剤
の第2容器、アルコール等低凝固点最終潅流液の
第3容器からコントローラーによる制御によつて
選択的に当該液剤を流液供給パイプに流出させる
液剤供給機構とからなり、上記臓器用温度制御機
構の給気パイプを前記断熱容器内の給気ノズルに
連結すると共に、液剤供給機構の流液供給パイプ
は同断熱容器内の臓器にあつて、その動脈または
門脈に連結自在であり、当該臓器の静脈に連結自
在な排出パイプを断熱容器外に延出するようにし
たことを特徴とする臓器の保存解凍用装置。 2 冷媒用温度制御機構は、コントローラーに接
続された温度センサー、電気ヒータと撹拌器とに
よつて構成されている特許請求の範囲第1項記載
の臓器の保存解凍用装置。 3 液剤供給機構の第1、第2、第3容器が冷却
槽内の冷媒中に浸漬され、当該各容器ごとに設け
られた第1、第2、第3開閉弁の開閉がコントロ
ーラーにより制御されるようにした特許請求の範
囲第1項記載の臓器の保存解凍用装置。 4 液剤供給機構の第1、第2、第3開閉弁とポ
ンプとの間に形成された熱交換部が、冷却槽内の
冷媒中に浸漬されている特許請求の範囲第1項記
載の臓器の保存解凍用装置。[Scope of Claims] 1. A perfusion freeze-thaw section and an insulated container in which internal organs can be freely removed. A refrigerant temperature control mechanism that can freely adjust the temperature of an organ temperature control mechanism connected to the air supply pipe; a first container for a blood homogenizing perfusate such as Collins'solution; a second container for a cryoprotectant such as dimethyl sulfoxide or glycerin; and a second container for a low freezing point final perfusate such as alcohol. a liquid agent supply mechanism for selectively flowing the liquid agent from a third container into a flowing liquid supply pipe under the control of a controller, and the air supply pipe of the organ temperature control mechanism is connected to an air supply nozzle in the heat insulating container. At the same time, the fluid supply pipe of the liquid supply mechanism can be freely connected to the artery or portal vein of an organ within the same insulated container, and the discharge pipe, which can be freely connected to the vein of the organ, is extended outside the insulated container. A device for preserving and thawing organs, characterized in that the organ is extracted. 2. The apparatus for preserving and thawing organs according to claim 1, wherein the refrigerant temperature control mechanism includes a temperature sensor connected to a controller, an electric heater, and a stirrer. 3. The first, second, and third containers of the liquid supply mechanism are immersed in the refrigerant in the cooling tank, and the opening and closing of the first, second, and third on-off valves provided for each container are controlled by the controller. An apparatus for preserving and thawing an organ according to claim 1. 4. The organ according to claim 1, wherein the heat exchange section formed between the first, second, and third on-off valves of the liquid supply mechanism and the pump is immersed in a refrigerant in a cooling tank. equipment for preserving and thawing.
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5659383A JPS59184101A (en) | 1983-03-31 | 1983-03-31 | Apparatus for storing and thawing organ |
| DE8383303133T DE3366419D1 (en) | 1982-06-04 | 1983-06-01 | Method of preserving organ and apparatus for preserving the same |
| EP83303133A EP0096997B1 (en) | 1982-06-04 | 1983-06-01 | Method of preserving organ and apparatus for preserving the same |
| CA000429420A CA1200507A (en) | 1982-06-04 | 1983-06-01 | Method of preserving organ and apparatus for preserving the same |
| US06/615,212 US4494385A (en) | 1982-06-04 | 1984-05-20 | Method of preserving organ and apparatus for preserving the same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP5659383A JPS59184101A (en) | 1983-03-31 | 1983-03-31 | Apparatus for storing and thawing organ |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS59184101A JPS59184101A (en) | 1984-10-19 |
| JPS6155882B2 true JPS6155882B2 (en) | 1986-11-29 |
Family
ID=13031491
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP5659383A Granted JPS59184101A (en) | 1982-06-04 | 1983-03-31 | Apparatus for storing and thawing organ |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS59184101A (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH035702A (en) * | 1989-06-01 | 1991-01-11 | Canon Inc | Cemented lens or the like and its manufacture |
-
1983
- 1983-03-31 JP JP5659383A patent/JPS59184101A/en active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS59184101A (en) | 1984-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4494385A (en) | Method of preserving organ and apparatus for preserving the same | |
| US4462215A (en) | Method of preserving organ and apparatus for preserving the same | |
| US4688387A (en) | Method for preservation and storage of viable biological materials at cryogenic temperatures | |
| JP2004503473A (en) | Cryopreservation of bioactive materials using high-temperature freezing | |
| CA1217350A (en) | Apparatus for freezing fertilized ova, spermatozoa or the like | |
| WO2000018226A3 (en) | Apparatus and method for maintaining and/or restoring viability of organs | |
| US20100233670A1 (en) | Frozen Viable Solid Organs and Method for Freezing Same | |
| AU2015302253B2 (en) | All-liquid cryoablation catheter | |
| CN111183095A (en) | Method and apparatus for temperature and pressure controlled cryopreservation | |
| CN113749753B (en) | Pressure adjusting method and device and cryosurgery system | |
| US7780712B2 (en) | Laparoscopic kidney cooling device | |
| JPS6156202B2 (en) | ||
| JPS6155882B2 (en) | ||
| JPS6156201B2 (en) | ||
| JPS6155881B2 (en) | ||
| JP2632531B2 (en) | How to preserve organs | |
| Schimmel et al. | Freezing of whole rat and dog kidney by perfusion of liquid nitrogen through the renal artery | |
| JP3239418B2 (en) | Method and apparatus for storing and regenerating living organs | |
| US20060178662A1 (en) | Warming gradient control for a cryoablation applicator | |
| RU2268590C1 (en) | Method for organs and tissues cryoconservation in situ | |
| Webb et al. | Hypothermic organ preservation: comparison of cooling and warming methods | |
| CN117398172A (en) | Control method of cryoablation instrument | |
| JPS6061502A (en) | Perfusion method and apparatus for preserving viscus | |
| CN117902184B (en) | A self-pressurized subcooled storage and transportation device for large-volume biological samples | |
| CN116678154B (en) | Fresh-keeping device and control method |